ABOUT EXOSMART™

What is exosmart?

exosmart is an advanced autologous plasma processing system designed to concentrate extracellular vesicles (EVs), platelet-derived secretome components and plasma proteins from a patient’s own blood. Using a proprietary ultrafiltration process, exosmart provides clinicians with a concentrated regenerative biologic prepared entirely from the patient’s own plasma.

Why choose exosmart?

exosmart combines advanced ultrafiltration technology with an efficient clinical workflow to provide a reproducible method of preparing an autologous regenerative biologic. Supported by clinician education, ongoing training and local Australian support from BioTrace Medical Solutions, exosmart offers practices a streamlined approach to integrating regenerative medicine into everyday clinical care.

How is exosmart different from PRP?

Traditional PRP focuses primarily on concentrating platelets. exosmart uses a different processing approach, concentrating extracellular vesicles together with platelet-derived secretome components and plasma proteins from platelet-rich plasma. This provides clinicians with an additional regenerative biologic option using the patient’s own blood.

Is exosmart autologous?

Yes. exosmart is a fully autologous system. The final concentrate is prepared exclusively from the patient’s own blood, with no donor-derived or synthetic biological materials added.

How long does the process take?

From blood collection to the final concentrate, the exosmart workflow is designed to integrate efficiently into clinical practice and is typically completed in approximately 30–40 minutes, depending on the clinic’s workflow.

What applications can it support?

exosmart is intended to prepare an autologous regenerative biologic for use by appropriately qualified healthcare professionals. Clinicians may choose to incorporate exosmart into a range of regenerative medicine workflows based on their own clinical judgement, applicable regulations and individual patient needs.

Why is extracellular vesicle concentration important?

Extracellular vesicles are naturally occurring biological messengers released by cells. They carry proteins, lipids and genetic material involved in cell-to-cell communication. exosmart is designed to concentrate extracellular vesicles together with other plasma-derived regenerative components from the patient’s own blood using its proprietary filtration process.

Who can use exosmart?

exosmart is designed for use by qualified healthcare professionals trained in blood collection, plasma preparation and regenerative medicine procedures, including doctors, specialists and other appropriately licensed clinicians.

EXOSOMES & REGENERATIVE TECHNOLOGY

What are autologous exosomes?

Autologous exosomes are extracellular vesicles derived from a patient’s own biological material. They are involved in cell-to-cell communication and carry biological signals including proteins and other molecules.

Technologies such as exosmart™ use a patient’s own plasma to concentrate extracellular vesicles and other regenerative components, providing an autologous approach for healthcare professionals exploring advanced regenerative technologies.

Are autologous exosomes available in Australia?

Yes. exosmart™ is available in Australia through BioTrace Medical Solutions for healthcare professionals and clinics interested in autologous regenerative technology.

Unlike donor-derived exosome products, exosmart uses the patient’s own blood as the starting material, creating an autologous preparation at the point of care.

For information about exosmart in Australia, including product information, training and demonstrations, contact BioTrace Medical Solutions.

What is exosmart™ Australia?

exosmart™ is an advanced plasma processing and ultrafiltration technology available to healthcare professionals in Australia through BioTrace Medical Solutions.

The system is designed to concentrate extracellular vesicles, platelets, growth factors and other regenerative components from a patient’s own plasma.

Because the preparation originates from the patient’s own blood, exosmart provides an autologous regenerative solution for healthcare professionals exploring emerging technologies in regenerative medicine.

How does exosmart™ concentrate exosomes?

exosmart™ uses advanced ultrafiltration technology to process a patient’s plasma and concentrate extracellular vesicles and other biologically active components.

The filtration process reduces excess plasma volume while retaining selected regenerative components, creating a concentrated autologous preparation from the patient’s own biological material.

What is the difference between exosmart™ and PRP?

PRP (Platelet-Rich Plasma) is primarily designed to concentrate platelets from a patient’s blood.

exosmart™ uses advanced ultrafiltration technology to further process plasma and concentrate extracellular vesicles alongside platelets, growth factors and other regenerative components.

Both approaches use the patient’s own blood, but the processing methods and resulting preparations are different.

Healthcare professionals should determine the appropriate technology based on the intended clinical application and applicable Australian regulatory requirements.

What are exosomes and how are they related to regenerative medicine?

Exosomes are small extracellular vesicles released by cells that play an important role in cell-to-cell communication. They can transport proteins, lipids and other biological signals between cells.

Because of their role in cellular communication, exosomes and extracellular vesicles are an area of significant scientific interest within regenerative medicine and regenerative technology.

BioTrace Medical Solutions provides healthcare professionals with access to emerging regenerative technologies, including exosmart™ autologous plasma processing technology.

What is regenerative technology?

Regenerative technology refers to technologies and medical approaches designed to work with or utilise the body’s own biological processes.

This may include technologies involving blood-derived components, platelets, growth factors, extracellular vesicles and other biological signalling mechanisms.

BioTrace Medical Solutions specialises in bringing advanced regenerative technologies and regenerative solutions to healthcare professionals across Australia.

Where can Australian clinics access exosmart™?

Australian healthcare professionals and clinics interested in exosmart™ can contact BioTrace Medical Solutions, the Australian provider of the technology.

BioTrace provides product information, education, training and support to healthcare professionals interested in incorporating advanced regenerative technology into their clinical practice.

Contact our team to discuss exosmart™, request further information or arrange a demonstration.

TRAINING, AVAILABILITY & SUPPORT

Is training provided?

Absolutely. BioTrace Medical Solutions provides comprehensive product training, clinical implementation support and ongoing education to ensure clinicians and their teams are confident in integrating exosmart into their practice.

Is clinical documentation available?

Yes. We provide healthcare professionals with clinical publications, technical documentation, treatment protocols and educational resources to support informed clinical decision-making and implementation.

How do I book a demo in Australia?

Booking a demonstration is simple. Contact the BioTrace team to arrange either an in-clinic demonstration or an online presentation. We’ll take you through the exosmart workflow, answer your questions and discuss how the system may integrate into your practice.